口服维生素D3补充剂对2型糖尿病患者的核因子-kB和血小板聚合的影响
Esraa Habiba1, Samia Ali1, Yehia Ghanem2
1Clinical Pharmacology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
维生素D补充剂,特别是口服形式,有助于调节血小板功能,并减少2型糖尿病患者的炎症. 这项研究发现,口服维生素D3改善了血小板聚合和含量,比通过肠道给予的剂量更有效.
科学领域:
- 内分泌学和新陈代谢学
- 血管生物学 血管生物学
- 营养科学 营养科学
背景情况:
- 血小板活性过高有助于糖尿病血管并发症和动脉样硬化.
- 维生素D不足在2型糖尿病患者中很常见.
- 活化血小板促进血管壁中的炎症反应.
研究的目的:
- 评估口服和肠道维生素D3补充剂对脂质特征,NF-κB,血小板聚合和血小板含量在2型糖尿病中的影响.
- 为了比较不同维生素D3剂量方案的疗效.
主要方法:
- 2型糖尿病患者每天 (4000 IU),每周 (50,000 IU) 服用口服维生素D3或单次肠道剂量 (300,000 IU) 持续3个月.
- 一个对照组只接受了抗糖尿病药物.
- 测量包括血清25(OH) D,脂质概况,NF-κB,血小板聚合和血小板含量.
主要成果:
- 所有维生素D3组都显示了血清25(OH) D水平的增加;口服剂量产生了比亲肠道更高的水平.
- 维生素D3补充剂降低了NF-κB水平,血小板聚合和血小板含量.
- 口服维生素D3疗法比单次管剂量更有效.
结论:
- 恢复维生素D水平对于维持正常的血小板功能和减少2型糖尿病炎症至关重要.
- 口服维生素D3补充剂在改善血小板参数方面似乎比单次肠道剂量更有益.
- 需要进一步的长期研究来证实这些发现.
更多相关视频
06:47Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells
Published on: May 4, 2018
10:46A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Dipeptidyl Peptidase 4 Inhibitors
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
